Bexarotene Gel Articles
Japan stock market week to Sept 11, 2006
18 September 2006
Ligand sells oncology line to Eisai and Avinza to King for total $518M
18 September 2006
Ligand's 2nd-qtr revenues up 10%, despite 15% loss growth
19 August 2002
FDA approves Ligand's Targretin gel
6 July 2000
Ligand's Targretin gel nears full US approval
14 June 2000
Ligand's Targretin gel gets priority review
10 February 2000
Lilly scraps Targretin development agreement with Ligand
24 February 1999
Showing 1-7 of 7 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
